Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Vical, Inc. (VICL) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Vical is dedicated to researching and developing biopharmaceutical products that are based on the company’s patented DNA delivery technologies for preventing and treating serious or life-threatening diseases. The company is internally developing specific infectious disease and cancer therapeutics. Vical additionally collaborates with major pharmaceutical and biotechnology companies, thereby gaining access to complementary technologies and resources that aid in expanding Vical’s product pipeline and addressing important unmet medical needs. For more information, visit the company’s Web site at www.vical.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *